Simplex Trading
IBIO icon

Simplex Trading’s iBio IBIO Stock Holding History

Simplex Trading’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,905
Closed -$66K – 9252
2023
Q3 		$66K Sell
10,905
-15
-0.1% -$130 ﹤0.01% 5538
2023
Q2 		$133K Sell
10,920
-695
-6% -$13.1K ﹤0.01% 4747
2023
Q1 		$483K Buy
11,615
+3,475
+43% +$89.4K ﹤0.01% 3300
2022
Q4 		$72K Buy
8,140
+7,816
+2,412% +$264K ﹤0.01% 5444
2022
Q3 		$27K Buy
324
+29
+10% +$3.99K ﹤0.01% 7187
2022
Q2 		$38K Buy
295
+13
+5% +$1.95K ﹤0.01% 6844
2022
Q1 		$60K Buy
282
+135
+92% +$28.2K ﹤0.01% 6880
2021
Q4 		$40K Sell
147
-27
-16% -$10.3K ﹤0.01% 7533
2021
Q3 		$132K Buy
174
+2
+1% +$1.25K ﹤0.01% 6227
2021
Q2 		$129K Buy
172
+171
+17,100% +$125K ﹤0.01% 6361
2021
Q1 		$100K Buy
+1
New +$871 ﹤0.01% 5750
2020
Q4 		– Sell
-1
Closed -$815 – 6910
2020
Q3 		$120K Buy
+1
New +$1.45K ﹤0.01% 4701

Other funds holding IBIO

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Simplex Trading's IBIO Position: Q4 2023 in Review

Simplex Trading sold out of iBio (IBIO) in Q4 2023, closing a stake of 670 shares — an estimated $4K sold.

Simplex Trading first reported a position in IBIO in Q3 2020 and held it in 9 quarters. The position peaked at $72K in Q1 2021. 21 funds tracked by Wall St. Rank hold IBIO as of Q4 2023.

  • Simplex Trading reported no remaining iBio position as of Q4 2023 after selling out during the quarter.
  • Simplex Trading sold 670 iBio shares in Q4 2023, an estimated $4K.
  • Simplex Trading first reported a position in iBio in Q3 2020 and held it in 9 quarters.
  • Simplex Trading's iBio position peaked at $72K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held iBio as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.